Rxsight, Inc. 8-K Summary: 2024 Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of the 2024 Annual Meeting of Stockholders held on June 6, 2024. Rxsight, Inc. (RXST), a Delaware corporation, reported that 30,022,322 shares were represented at the meeting, constituting approximately 80.8% of the 37,173,544 shares outstanding as of the record date (April 8, 2024).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Outcomes
The following matters were submitted to a vote of security holders:
- Election of Directors: Three Class III director nominees were re-elected to serve until the 2027 annual meeting:
- Julie B. Andrews: 18,202,611 votes For; 5,913,897 Withheld.
- Robert J. Palmisano: 18,202,323 votes For; 5,914,185 Withheld.
- Tamara R. Fountain, M.D.: 18,195,702 votes For; 5,920,806 Withheld.
- Advisory Vote on Executive Compensation (Say-on-Pay): Stockholders approved the compensation of named executive officers.
- For: 22,608,292
- Against: 1,123,950
- Abstain: 395,359
- Frequency of Say-on-Pay Votes: Stockholders approved holding advisory votes on executive compensation annually ("One Year").
- One Year: 20,463,835 votes
- Two Years: 5,400 votes
- Three Years: 1,196,918 votes
- Ratification of Auditors: The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified.
- For: 29,885,111
- Against: 46,027
- Abstain: 91,184
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document confirms that future advisory votes on executive compensation will occur every year, with the next frequency vote required no later than the 2030 annual meeting.
Key Facts for Investor Verification
- Verify the re-election of the three Class III directors and their tenure through 2027.
- Confirm the company's commitment to annual Say-on-Pay votes based on the shareholder preference.
- Note the strong ratification of Ernst & Young LLP as the independent auditor for fiscal year 2024.
- Review the significant number of broker non-votes (approx. 5.9 million) recorded across the director and compensation proposals.